BridgeBio Pharma’s Pipeline Expansion Continues As Existing Portfolio’s Milestones Approach

 
• By Mandy Jackson
white pills with bottle on blue background. genetic diseases concept
BridgeBio's genetic disease drug candidates span small molecules, biologics and gene therapies • Source: Shutterstock

More from Strategy

More from Business